Scholar Probes New Brain Cancer Pathway with $50k Grant from AANS Section on Tumors

Share

Kazutaka Sumita, MD, PhD, a fellow in the Department of Hematology-
Oncology, in his lab at the Vontz Center for Molecular Studies at UC. Photo by Cindy Starr / Mayfield Clinic.

Kazutaka “Kazu” Sumita, MD, PhD, knows how to meet a challenge. He earned his doctoral and medical degrees at Tokyo Medical & Dental University and then trained to become a brain surgeon. To date, he has performed more than 1,300 surgeries, including a particularly terrifying one. When the Higashi nihon daishinsa –the Great East Japan Earthquake — struck off the Pacific coast of Tōhoku in 2011, triggering the deadly tsunami, Dr. Sumita was performing an endovascular treatment. The lights went out and all power was lost for an hour, but he managed to finish the operation safely and save his patient.

Dr. Sumita, a post-doctoral fellow in the Division of Hematology-Oncology and a researcher at the Brain Tumor Center at the UC Neuroscience Institute and UC Cancer Institute, today faces an equally big challenge: He has been awarded a $50,000 grant — the American Association of Neurological Surgeons (AANS) Section on Tumors/Brainlab International Research Fellowship — to pursue a novel laboratory study of malignant brain tumors. The grant allows a foreign neurosurgeon to perform clinical, translational or basic research in the field of neurosurgical oncology in a clinical and/or laboratory setting within the United States.

Details of Dr. Sumita’s work will be published in a scientific report in a couple of years. He is targeting an energy pathway that enables malignant primary and metastatic brain tumors to grow and spread. More specifically, he is studying phosphoinositide signaling. Phosphoinositide is a cellular messenger that plays a role in controlling cellular activities such as growth and proliferation. Once cells have lost control of phosophoinositide signaling, the risk for disease, particularly cancer, increases.

“We are looking for pathways that are important for the survival of brain cancer cells,” Dr. Sumita said. “We want to identify these pathways so that we can stop the growth of primary brain cancers (such as glioblastoma) as well as metastatic brain tumors. The pathway we are now discovering is a new signaling pathway; it will be a sensational finding, and when we interfere with this pathway, we expect to see a decrease in tumor growth.

“Right now we do not understand how it is happening or what molecular mechanism is making it slow down. The fellowship will enable us to decipher the cause.”

Atsuo Sasaki, PhD, Assistant Professor in the Division of Hematology-Oncology at UC and Dr. Sumita’s scientific mentor, said Dr. Sumita “is likely to discover the central energy status” in cancer cells that have changed from normal brain cells.

“This is an important component of tumor therapy,” he said. “Ideally, we do not want to kill normal cells during treatment, yet this is a major problem with chemotherapy. People suffer side-effects because the therapy also acts on normal tissue. What Dr. Sumita has found is the clue for a brain tumor-specific energy pathway, or energy utilization pathway. We think that this pathway is linked to the phosphoinositide signaling pathway.”

If such a pathway could be targeted with medication, the researchers said, it would give doctors a way to combat cancer cells without harming healthy cells.

Physician-scientists like Dr. Sumita bring a valuable perspective to the study of disease. They can seamlessly introduce the important clinical questions into the laboratory and then test the lab findings in Phase 1 clinical trials. If successful, Phase 1 trials can ultimately lead to a clinically relevant therapy.

“Kazu believes that basic science will help him find a way to cure patients suffering from brain tumors, trauma or neurovascular disease,” Dr. Sasaki said.  “During his clinical work he had many patients who suffered from malignant brain tumors. Surgery helps, but it is not a complete solution. He is pursuing this training to find a cure for brain tumors.

“His aspirations are high,” Dr. Sasaki continued. “He is a really dedicated researcher and clinician, and you see him at the lab almost 24-7.”

“We have a great clue,” Dr. Sumita said. “We want to understand this pathway in a year or two. No other researchers are looking at this pathway. We want to be the first.”

– Cindy Starr

This entry was posted in UCNI Weekly Blog and tagged . Bookmark the permalink. Both comments and trackbacks are currently closed.
  • Print This Page
  • Make an Appointment: Schedule Now
  • UCNI Weekly Blog
  • Hope Stories

    • Jim’s Story: Pituitary Tumor

      Jim's Story: Pituitary Tumor One turn of events led to another, and so it was that Jim, and not his wife, took Jim’s 87-year-old father to his appointment with the dermatologist for the first time. And so it was that the dermatologist was not...
    • Kevin’s Story: Acoustic Neuroma

      Kevin's Story: Acoustic Neuroma Kevin was in his mid-40s when he began to notice that he wasn’t hearing quite as well as in the past. But the change was gradual, so he didn’t worry about it. A few years went by, and the hearing...
    • Doc’s Story: Metastatic Brain Tumors

      Doc’s Story: Metastatic Brain Tumors First there were headaches. Bad ones. Migraines, probably. Then, one day in mid-May, 2010, his knee, foot and arm went numb on his left side. Darrell “Doc” Rodgers, the 700WLW radio personality, feared he was having a stroke. In the emergency...
    • Brian’s Story: Meningioma

      Brian's Story: Meningioma “Carefree” is the word Brian uses to describe his life back then. He was 39 years old, happily married and the father of three children under the age of 5. “Life was busy, but that felt normal,” he says, reflecting. “The only...
    • Dr. Mike’s Story: Glioblastoma

      Dr. Mike's Story: Glioblastoma Nearly two years after receiving a diagnosis of brain cancer, Dr. Michael Wood continues to attack his disease with wellness. In addition to surgery, radiation, chemotherapy and strong family support, the Cincinnati otolaryngologist has worked hard to provide his own...
    • Joe’s Story: Oligodendroglioma

      Joe's Story: Oligodendroglioma Joe calls it a miracle and a gift from “a higher power.” Others might call it a fortuitous turn of fate. Either way, Joe’s experience embodies a reversal of fortune that is both wonderful and startling. Once a man with...
    • Lynne’s Story: Brain Metastasis

      Lynne's Story: Brain Metastasis Semiretired and working part-time at a restaurant, Lynne knew something was amiss when she looked at the cash register and then struggled to make her hands produce the correct amount of change. Could she have suffered a stroke? Lynne pushed the...
    • Jerry’s Story: Spinal Tumor

      Jerry's Story: Spinal Tumor On an ordinary day in February 2009, John M. Tew, MD, got one of the true surprises of his career. He was seeing patients in his Mayfield Clinic office on the University of Cincinnati medical campus when an unexpected guest...
    • Blake’s Story: Medulloblastoma

      Blake's Story: Medulloblastoma Blake knew he was in the right hands the moment he saw the surgeon’s wrists. Dr. John M. Tew, Blake’s neurosurgeon, was wearing one of Lance Armstrong’s yellow LiveStrong cancer bracelets. So was Blake. Dr. Tew, who was also sporting...
    • Bob’s Story: Glioblastoma

      Bob's Story: Glioblastoma Bob’s story blends coincidence with collaboration and hope. The coincidence involves the 62-year-old West Chester man’s best buddy, “Jake,” a 165-pound...
    • Sandra’s Story Glioma

      Sandra's Story Glioma Sandra (Sandy) is a smiling, breathing reminder that hope exists for patients with even the most challenging type of brain tumors. Nine years ago, when Sandy was first told that she had six months to live, she stared back blankly...
    • John’s Story: Glioblastoma

      John's Story: Glioblastoma John, a retired painter and carpenter, is a tall, solidly built man with a strong inclination toward getting things done. A former Vista volunteer who was equally comfortable running a food co-op in an underserved neighborhood or standing near the...